Coded Growth Innovation Center Inc. Stock Analysis DMSI
United States Health Care Nano Cap Dermisonics, Inc. engages in the provision of medical technology services. The company is headquartered in Henderson, Nevada. The company went IPO on 2003-07-11. The Company’s principal activity is to provide drugs delivery system. Its Transdermal systems deliver drugs through the skin into the bloodstream. Medications delivered via skin patches avoid liver metabolism, a necessary feature for drug molecules to metabolize easily, and allows for lower dosing of medications. There are two types of transdermal delivery systems: passive and active. In passive transdermal systems, the drug diffuses through the skin where it can act locally or penetrate the capillaries for systemic effect. Active patches require a physical force to facilitate the movement of drug molecules across the skin. The company is a development stage company.
Read More Coded Growth Innovation Center Inc (DMSI) Chart
Key Statistics of Coded Growth Innovation Center Inc (DMSI)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
765.00P/E Ratio (TTM)
-52 Week Range
Market Cap
830.80Avg. Volume
765.00Dividend Yield
-Financial Metrics & Statements of Coded Growth Innovation Center Inc (DMSI)
FAQ's for Coded Growth Innovation Center Inc (DMSI)
- According to Musaffa’s Shariah screening methodology, Coded Growth Innovation Center Inc (DMSI) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.